Farbod Fazlollahi

Mr. Farbod Fazlollahi

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2014 in Nature
Verified
Journal Article
Closed access
PDF file
RCRandall M. Chin
Randall M. Chin
XFXudong Fu
Xudong Fu
MPMelody Y. Pai
Melody Y. Pai
LVLaurent Vergnes
Laurent Vergnes
HHHeejun Hwang
Heejun Hwang
JHJing Huang
Jing Huang

1 September 2015 in Cell Metabolism
Verified
Journal Article
Closed access
XFXudong Fu
Xudong Fu
RCRandall M. Chin
Randall M. Chin
LVLaurent Vergnes
Laurent Vergnes
HHHeejun Hwang
Heejun Hwang
GDGang Deng
Gang Deng
JHJing Huang
Jing Huang

2 June 2014 in eLife
Verified
Journal Article
Open access
TBTammy J Bullwinkle
Tammy J Bullwinkle
NRNoah M Reynolds
Noah M Reynolds
MRMedha Raina
Medha Raina
AMAdil Moghal
Adil Moghal
EMEleftheria Matsa
Eleftheria Matsa
MIMichael Ibba
Michael Ibba
Aminoacyl-tRNA synthetases use a variety of mechanisms to ensure fidelity of the genetic code and ultimately select the correct amino acids to be used in protein synthesis. The physiological necessity of these quality control mechanisms in different environments remains unclear, as the cost vs benefit of accurate protein synthesis is difficult to predict. We show that in Escherichia coli, a non-coded amino acid produced through oxidative damage is a significant threat to the accuracy of protein synthesis and must be cleared by phenylalanine-tRNA synthetase in order to prevent cellular toxicity caused by mis-synthesized proteins. These findings demonstrate how stress can lead to the accumulation of non-canonical amino acids that must be excluded from the proteome in order to maintain cellular viability.

5 April 2021 in Journal of Neurotrauma
Verified
Journal Article
Closed access
DLDaniel C. Lu
Daniel C. Lu
ZZZsolt Zador
Zsolt Zador
JYJinghua Yao
Jinghua Yao
FFFarbod Fazlollahi
Farbod Fazlollahi
GMGeoffrey T. Manley
Geoffrey T. Manley
Seizures are important neurological complications after traumatic brain injury (TBI) and are reported for up to 50% of patients with TBI. Despite several studies, no drug strategy has been able to alter the biological events leading to epileptogenesis. The glial water channel, aquaporin-4 (AQP4), was shown to facilitate cytotoxic cell swelling in ischemia and glial scar formation after stab wound injury. In this study, we examined post-traumatic seizure susceptibility of AQP4-deficient mice (AQP4 –/– ) after injection of pentylenetetrazole (PTZ) 1 month after controlled cortical impact (CCI) and compared them to wild-type sham injury controls. After PTZ injection, AQP4 –/– mice demonstrated dramatically shortened seizure latency (120 ± 40 vs. 300 ± 70 sec; p < 0.001) and increased seizure severity (grade 7.5 ± 0.4 vs. 5.8 ± 0.4; p < 0.001) compared to their wild-type counterparts. Morphometric analysis demonstrated a significant 2-fold reduction in astrocytosis, with a concomitant increase in microgliosis in injured AQP4-null mice compared to their injured wild-type counterparts (44 ± 2 vs. 24 ± 3 cells per high power field [cells/hpf], respectively; p < 0.0001). Minocycline, an inhibitor of microglia, reversed the post-TBI epilepsy phenotype of AQP4-null mice. After minocycline treatment, AQP4 –/– mice demonstrated similar latency of seizures evoked by PTZ (723 ± 35 vs. 696 ± 38 sec; p > 0.05) and severity of seizures evoked by PTZ (grade 4.0 ± 0.5 vs. 3.81 ± 0.30; p > 0.05) compared to wild-type counterparts. Immunohistochemical analysis demonstrated decreased immunostaining of microglia to levels comparable to wild-type (12 ± 2 vs. 11 ± 4 cells/hpf, respectively; p > 0.05). Taken together, these results suggest a protective role of AQP4 in post-traumatic seizure susceptibility by promoting astrogliosis, formation of a glial scar, and preventing microgliosis.

8 March 2013
Verified
Book Chapter
Closed access
PDF file
TGThomas C. Glenn
Thomas C. Glenn
DHDaniel Hirt
Daniel Hirt
GMGustavo Mendez
Gustavo Mendez
DMDavid L. McArthur
David L. McArthur
RSRachael Sturtevant
Rachael Sturtevant
NMNeil A. Martin
Neil A. Martin

5 July 2017 in mBio
Verified
Journal Article
Open access
PDF file
AMAnthony Mitchell
Anthony Mitchell
CTChristina Tam
Christina Tam
DEDerek Elli
Derek Elli
TCThomas Charlton
Thomas Charlton
POPatrick Osei-Owusu
Patrick Osei-Owusu
OSOlaf Schneewind
Olaf Schneewind
Glutathionylation, the formation of reversible mixed disulfides between glutathione and protein cysteine residues, is a posttranslational modification previously observed for intracellular proteins of bacteria. Here we show that Yersinia pestis LcrV, a secreted protein capping the type III secretion machine, is glutathionylated at Cys 273 and that this modification promotes association with host ribosomal protein S3 (RPS3), moderates Y. pestis type III effector transport and killing of macrophages, and enhances bubonic plague pathogenesis in mice and rats. Secreted LcrV was purified and analyzed by mass spectrometry to reveal glutathionylation, a modification that is abolished by the codon substitution Cys 273 Ala in lcrV . Moreover, the lcrV C273A mutation enhanced the survival of animals in models of bubonic plague. Investigating the molecular mechanism responsible for these virulence attributes, we identified macrophage RPS3 as a ligand of LcrV, an association that is perturbed by the Cys 273 Ala substitution. Furthermore, macrophages infected by the lcrV C273A variant displayed accelerated apoptotic death and diminished proinflammatory cytokine release. Deletion of gshB , which encodes glutathione synthetase of Y. pestis , resulted in undetectable levels of intracellular glutathione, and we used a Y. pestis Δ gshB mutant to characterize the biochemical pathway of LcrV glutathionylation, establishing that LcrV is modified after its transport to the type III needle via disulfide bond formation with extracellular oxidized glutathione. IMPORTANCE Yersinia pestis , the causative agent of plague, has killed large segments of the human population; however, the molecular bases for the extraordinary virulence attributes of this pathogen are not well understood. We show here that LcrV, the cap protein of bacterial type III secretion needles, is modified by host glutathione and that this modification contributes to the high virulence of Y. pestis in mouse and rat models for bubonic plague. These data suggest that Y. pestis exploits glutathione in host tissues to activate a virulence strategy, thereby accelerating plague pathogenesis.